Published in J Physiol on April 25, 2003
Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal (2005) 1.58
Cardiac mitochondria and arrhythmias. Cardiovasc Res (2010) 1.29
Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation (2008) 1.24
Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol (2009) 1.06
Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overload. PLoS One (2012) 0.95
Mitochondria are sources of metabolic sink and arrhythmias. Pharmacol Ther (2011) 0.92
Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol (2007) 0.91
Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection. Am J Physiol Heart Circ Physiol (2014) 0.83
Mechanisms of sudden cardiac death: oxidants and metabolism. Circ Res (2015) 0.83
Caveolin and caveolae in age associated cardiovascular disease. J Geriatr Cardiol (2013) 0.82
KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82
Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance. Rejuvenation Res (2012) 0.81
Mitochondria and arrhythmias. Free Radic Biol Med (2014) 0.81
Cardioprotective trafficking of caveolin to mitochondria is Gi-protein dependent. Anesthesiology (2014) 0.81
Caveolins in cardioprotection - translatability and mechanisms. Br J Pharmacol (2015) 0.80
Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium. Exp Gerontol (2013) 0.80
Cardiovascular KATP channels and advanced aging. Pathobiol Aging Age Relat Dis (2016) 0.75
Adenosine for postoperative analgesia: A systematic review and meta-analysis. PLoS One (2017) 0.75
Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. J Mol Cell Cardiol (2001) 3.01
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation (1998) 2.79
K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol (2002) 2.18
The mitochondrial KATP channel as a receptor for potassium channel openers. J Biol Chem (1996) 1.77
Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res (2000) 1.71
Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res (2001) 1.69
Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys (2002) 1.52
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43
Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A (1997) 1.41
Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol (1996) 1.28
Intrinsic A(1) adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts. Am J Physiol Heart Circ Physiol (2000) 1.23
Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation (2002) 1.22
Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res (1996) 1.19
Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2001) 1.18
Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol (2001) 1.09
ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol (2002) 1.03
Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol (1994) 1.00
Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol (2000) 1.00
Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg (2000) 0.98
Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart. J Lab Clin Med (1994) 0.97
Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation (1993) 0.97
Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart. Exp Physiol (2001) 0.94
Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. J Mol Cell Cardiol (2001) 0.93
Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation (1997) 0.93
Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol (2002) 0.93
Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Circulation (1995) 0.92
Age-dependent changes in myocardial susceptibility to zero flow ischemia and reperfusion in isolated perfused rat hearts: relation to antioxidant status. Mech Ageing Dev (1998) 0.89
Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation. J Mol Cell Cardiol (1998) 0.88
Age-dependent sensitivity to unprotected cardiac ischemia: the senescent myocardium. J Thorac Cardiovasc Surg (1992) 0.88
Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol (2000) 0.88
Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur J Biochem (2001) 0.88
Ischemic threshold and myocardial stunning in the aging heart. Exp Gerontol (1999) 0.87
Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol (2002) 0.87
Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol (2001) 0.87
Age-dependent effects of ischemia and reperfusion on cardiac function and Ca2+ transport in myocardium. Gerontology (1991) 0.86
Cardioprotection by K(ATP) channels in wild-type hearts and hearts overexpressing A(1)-adenosine receptors. Am J Physiol Heart Circ Physiol (2000) 0.85
Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol (1998) 0.85
Age-associated alterations in cardiac and skeletal muscle glucose transporters, insulin and IGF-1 receptors, and PI3-kinase protein contents in the C57BL/6 mouse. Mech Ageing Dev (1999) 0.85
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res (1994) 0.85
Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol (2000) 0.84
Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat. J Cardiovasc Pharmacol (1998) 0.83
Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning. J Mol Cell Cardiol (2001) 0.82
Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol Heart Circ Physiol (2000) 0.80
Reduced adenosine A1 receptor and G alpha protein coupling in rat ventricular myocardium during aging. Circ Res (1997) 0.80
The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology (2002) 0.80
Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection. J Mol Cell Cardiol (1996) 0.79
ATP catabolism and adenosine generation during ischemia in the aging heart. Mech Ageing Dev (1996) 0.79
Age-related incidence of reperfusion- and reoxygenation-induced ventricular tachyarrhythmias in the isolated rat heart. Gerontology (1985) 0.78
Loss of protection by hypoxic preconditioning in aging Fischer 344 rat hearts related to myocardial glycogen content and Na+ imbalance. Cardiovasc Res (1999) 0.78
The effect of age on adenosine A1 receptor function in the rat heart. J Mol Cell Cardiol (1997) 0.77
Effects of fasting and exogenous glucose delivery on cardiac tolerance to low-flow ischemia in adult and senescent rats. Mech Ageing Dev (2000) 0.77
Integration of vascular, contractile and metabolic responses to hypoxia: effects of maturation and adenosine. Am J Physiol (1996) 0.76
Cost efficiency in the detection of chytridiomycosis using PCR assay. Dis Aquat Organ (2006) 1.91
Age-related changes in ischemic tolerance in male and female mouse hearts. J Mol Cell Cardiol (2004) 1.77
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics (2009) 1.77
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation (2009) 1.72
Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res (2006) 1.52
Effect of cardiac A(1) adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res (2002) 1.46
Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med (2011) 1.37
Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol (2003) 1.30
Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res (2003) 1.18
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc (2013) 1.18
Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2005) 1.17
Cardiac and coronary function in the Langendorff-perfused mouse heart model. Exp Physiol (2008) 1.08
Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med (2012) 1.07
Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovasc Res (2002) 1.02
Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med (2010) 1.01
Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther (2013) 0.99
Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. Am J Physiol Heart Circ Physiol (2002) 0.98
Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart. Cardiovasc Res (2002) 0.98
Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am J Physiol Heart Circ Physiol (2003) 0.96
Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res (2005) 0.95
Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol (2002) 0.93
Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation (2013) 0.92
Genetic modulation of adenosine receptor function and adenosine handling in murine hearts: insights and issues. J Mol Cell Cardiol (2006) 0.89
Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Affect Disord (2012) 0.87
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol (2003) 0.86
Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart. Life Sci (2005) 0.85
A3 adenosine receptor-mediated protection of the ischemic heart. Vascul Pharmacol (2005) 0.85
Adenosine-mediated cardioprotection in the aging myocardium. Cardiovasc Res (2004) 0.84
Impact of wall thickness on conduit artery function in humans: is there a "Folkow" effect? Atherosclerosis (2011) 0.84
Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC. J Am Coll Cardiol (2014) 0.83
Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol (2002) 0.83
Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium. Biochem Biophys Res Commun (2003) 0.82
Time course-dependent changes in the transcriptome of human skeletal muscle during recovery from endurance exercise: from inflammation to adaptive remodeling. J Appl Physiol (1985) (2013) 0.82
Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A(1)-adenosine receptors. Br J Pharmacol (2003) 0.82
Voluntary running in mice beneficially modulates myocardial ischemic tolerance, signaling kinases, and gene expression patterns. Am J Physiol Regul Integr Comp Physiol (2012) 0.81
Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81
Endogenous adenosine selectively modulates oxidant stress via the A1 receptor in ischemic hearts. Antioxid Redox Signal (2009) 0.80
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis. J Mol Cell Cardiol (2005) 0.80
On the biological relevance of a single Batrachochytrium dendrobatidis zoospore: a reply to Smith. Dis Aquat Organ (2007) 0.79
Percutaneous device closure of atrial septal defect in a premature infant with rapid improvement in pulmonary status. Pediatrics (2007) 0.79
Assessment of DNA degradation and the genotyping success of highly degraded samples. Int J Legal Med (2010) 0.79
Transesophageal echocardiographic guidance for surgical repair of aortic insufficiency in congenital heart disease. J Am Soc Echocardiogr (2007) 0.79
Effects of A1 adenosine receptor overexpression on normoxic and post-ischemic gene expression. Cardiovasc Res (2003) 0.78
The adenosine A₂A receptor - myocardial protectant and coronary target in endotoxemia. Int J Cardiol (2011) 0.78
Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine. Exp Physiol (2006) 0.78
Elasmobranch qPCR reference genes: a case study of hypoxia preconditioned epaulette sharks. BMC Mol Biol (2010) 0.77
Age-associated shifts in cardiac gene transcription and transcriptional responses to ischemic stress. Exp Gerontol (2005) 0.77
Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors. Cardiovasc Res (2003) 0.77
Cardiovascular magnetic resonance of pulmonary artery growth and ventricular function after Norwood procedure with Sano modification. J Cardiovasc Magn Reson (2008) 0.77
Transcriptional responses to hypoxia are enhanced by recurrent hypoxia (hypoxic preconditioning) in the epaulette shark. Physiol Genomics (2012) 0.76
Myocardial function following cold ischemic storage is improved by cardiac-specific overexpression of A1-adenosine receptors. Can J Physiol Pharmacol (2005) 0.76
A1 adenosine receptor overexpression decreases stunning from anoxia-reoxygenation: role of the mitochondrial K(ATP) channel. Basic Res Cardiol (2002) 0.76
Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors. Physiol Genomics (2002) 0.76
Use of an administrative database to determine clinical management and outcomes in congenital heart disease. World J Pediatr Congenit Heart Surg (2011) 0.75
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes (2017) 0.75
Task Force 1: Pediatric Cardiology Fellowship Training in General Cardiology. SPCTPD/ACC/AAP/AHA. Circulation (2015) 0.75
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol (2017) 0.75
Task Force 1: Pediatric Cardiology Fellowship Training in General Cardiology. J Am Coll Cardiol (2015) 0.75